Article Details
Retrieved on: 2024-05-01 15:37:19
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses advancements in hypercholesterolemia treatment, emphasizing alternatives to statins due to limitations and intolerance observed in some patients. It highlights the role of PCSK9 inhibitors and newer therapies in improving public health outcomes for lipid metabolism disorders and familial hypercholesterolemia. Key figures at Case Western Reserve University provide insights into future cardiovascular care.
Article found on: www.managedhealthcareexecutive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here